AssayIndex

AX-2026-042172

Melanotan II · 10 mg declared · Guangzhou JEEP Biotechnology Co., Ltd. · lot JEEP-2604-R9103

PASSVERIFIED
Report ID
AX-2026-042172
Compound
Melanotan II
Compound class
Melanocortin-receptor peptides
Supplier
JEEP — Guangzhou JEEP Biotechnology Co., Ltd.
Batch / lot
JEEP-2604-R9103
Declared label claim
10mg
Laboratory
VendorInvestigate
Assay date
19 May 2026
Submitted
03 Jun 2026
Quarter
2026-Q2
Submitter
a.okonkwo
Sample provenance
Buyer-sourced
Section 1

Results

Measured against the index acceptance specification for the melanocortin-receptor peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

ParameterMethodResultUnitIndex spec
PurityRP-HPLC, 32 min gradient, 214 nm99.72% area≥ 98.5PASS
Total impuritiesRP-HPLC, sum of reported peaks0.28% area≤ 1.5PASS
Largest single impurityRP-HPLC — linear (open-lactam) precursor (+18 Da)0.18% area≤ 1.00PASS
Identity — theoretical monoisotopic masscalculated from molecular formula1023.5402DaNOT TESTED
Identity — observed monoisotopic massLC-MS, high resolution (ESI-TOF/QTOF)1023.5385DaNOT TESTED
Mass accuracyobserved vs theoretical-1.7ppm± 15PASS
Total peptide contentby difference from the gravimetric mass balance89.83%w/wNOT TESTED
Target-compound contenttotal peptide content × purity89.58%w/wNOT TESTED
Gross fill (as weighed)five-place balance, under nitrogen11.80mg10 mg declaredNOT TESTED
Recovered target peptidegross fill × target content10.570mg10 mg claimNOT TESTED
Recovery against label claimrecovered ÷ claim105.7%90.0 – 110.0PASS
Water contentKarl Fischer, coulometric, duplicate5.39%≤ 8.0PASS
Counter-ion (acetate)anion-exchange ion chromatography3.91%≤ 10.0PASS
Residual solvent + inorganic residueestimated — see /methods/residual-solvents-q3c/0.87%NOT TESTED
Endotoxinkinetic chromogenic LAL0.39EU/mg≤ 5.0PASS
Sterilitymembrane filtration, USP <71>, 14 dNo growth at 14 dno growthPASS
Appearancevisual, diffuse light, black and white backgroundWhite powder, no defined cake (melt-back)white to off-white intact cakeFAIL
Reconstitution clarityreconstituted per submitter procedureClear, colourless, no visible particulatesclear, no visible particulatesPASS
pH (reconstituted, 1 mg/mL)potentiometric, two-point calibration4.232.5 – 8.0PASS
Retention time (observed)RP-HPLC, 32 min gradient10.46min10.44 ± 0.25 (normalised)PASS
Peak asymmetry (10 % height)Ph. Eur. 2.2.461.280.80 – 1.50PASS
Plate count, main peakN = 5.54 (t/w½)²55,658≥ 20,000PASS
Resolution to nearest impurityvs [L-Phe7]-diastereomer0.94no index criterionREPORTED
Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

02284456868519135 Melanotan II10.46 min · 99.72 % 9.67 same trace · ×200 vertical expansion, baseline-corrected · main peak off-scale reporting threshold 0.05 % area 05101520253035 Retention time (min) Response (mAU)
Figure 1. RP-HPLC trace, 32 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 55,658, and skew follows the reported asymmetry factor of 1.28. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.18 % impurity against a 99.72 % main peak is a line two pixels tall; the main peak runs off-scale there by design.
#PeakRTArea (µV·s)% areaΔ mass (Da)
1Melanotan II — main peak10.464,846,70199.72
2linear (open-lactam) precursor (+18 Da)9.678,7490.18+18.011
3des-acetyl MT-II (−42 Da)9.952,4300.05-42.011
4[L-Phe7]-diastereomer10.291,4580.030.000
5oxidised Trp (+16 Da)10.089720.02+15.995
Closure check — purity + Σ impurities 100.00CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 1023.5402 Da, computed from C50H69N15O9. All ppm figures on this site are against monoisotopic values — see why that matters.

025507510025040055070085010001150 [M+1H]1+1024.55[M+2H]2+512.78 m/z Relative abundance (%)
Figure 2. ESI charge-state envelope, high-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 1023.5385 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.
ChargeTheoretical m/zObserved m/zΔ m/zRel. abundance (%)
3+342.1873342.1868-0.00057.8
2+512.7774512.7765-0.000957.5
1+1024.54751024.5458-0.0017100.0
Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

ComponentDetermination%w/w of cake
WaterKarl Fischer5.39
Counter-ion (acetate)ion chromatography3.91
Residual solvent + inorganic residueestimated0.87
Total peptide contentby difference89.83
Total100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

FigureSupplier COAThis reportIndex note
Purity (% area)99.1499.72divergence -0.36 pp vs batch median
Total impurities (% area)0.860.28
Largest single impurity (% area)not stated0.18
Water (%)not stated5.39
Counter-ion (%)9.13.91
Peptide content (%w/w)86.889.83
Endotoxin (EU/mg)not stated0.39
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance
Buyer-sourced
Evidentiary weight
Strongest available evidence in this index.
Chain of custody
Retail purchase → third-party forwarder (27 d) → laboratory (courier, cold pack, 2 d) → assay.
Assay date
19 May 2026
Submitted to the index
03 Jun 2026
Laboratory
VendorInvestigate, Riga, Latvia
Method basis
32 min gradient · high-resolution MS
Verification status
VERIFIED
Section 6

Annotations 2

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

diode_array
Photodiode-array spectral homogeneity across the main peak would convert 99.72 % from a good number into a checked one. It is a free measurement on any instrument that already has the detector.
ms_confirm
-1.7 ppm at this mass is a clean identity confirmation. With retention at 10.46 min, Melanotan II is established as the species measured. Note what it does not exclude: a mass-identical diastereomer, which no mass measurement of any resolution can.
Section 7

Related records

Same batch — lot JEEP-2604-R9103 n=13

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042164JEEP-2604-R9103Janoshik2026-Q299.545.23Buyer-sourced1MARGINAL
AX-2026-042165JEEP-2604-R9103Janoshik2026-Q299.765.24Buyer-sourced0PASS
AX-2026-042166JEEP-2604-R9103Janoshik2026-Q299.404.75Buyer-sourced0PASS
AX-2026-042167JEEP-2604-R9103Nordanalyt2026-Q299.905.71Laboratory-retained0PASS
AX-2026-042168JEEP-2604-R9103Nordanalyt2026-Q299.405.71Buyer-sourced0PASS
AX-2026-042169JEEP-2604-R9103Janoshik2026-Q299.435.22Buyer-sourced0PASS
AX-2026-042170JEEP-2604-R9103Medutest2026-Q299.925.07Buyer-sourced0PASS
AX-2026-042171JEEP-2604-R9103Kestrel2026-Q299.595.11Buyer-sourced0PASS
AX-2026-042173JEEP-2604-R9103Janoshik2026-Q299.385.31Buyer-sourced0PASS
AX-2026-042174JEEP-2604-R9103PeptideMeter2026-Q299.225.42Buyer-sourced0PASS
AX-2026-042175JEEP-2604-R9103Janoshik2026-Q299.195.45Buyer-sourced0PASS
AX-2026-042176JEEP-2604-R9103Janoshik2026-Q299.504.88105.3Buyer-sourced0PASS
Other recent Melanotan II records in the index.
ReportSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042757GGPepsGGPE-2603-P1474Janoshik2026-Q399.546.7892.0Buyer-sourced0PASS
AX-2026-042756GGPepsGGPE-2603-P1474Nordanalyt2026-Q399.177.04Buyer-sourced0PASS
AX-2026-042755GGPepsGGPE-2603-P1474Nordanalyt2026-Q399.256.5890.4Buyer-sourced0PASS
AX-2026-042760GGPepsGGPE-2603-P1474Medutest2026-Q399.437.02Buyer-sourced0PASS
AX-2026-042758GGPepsGGPE-2603-P1474PeptideMeter2026-Q399.236.96Buyer-sourced0PASS
AX-2026-042759GGPepsGGPE-2603-P1474Janoshik2026-Q399.156.71105.1Buyer-sourced0PASS
AX-2026-042168JEEPJEEP-2604-R9103Nordanalyt2026-Q299.405.71Buyer-sourced0PASS
AX-2026-042164JEEPJEEP-2604-R9103Janoshik2026-Q299.545.23Buyer-sourced1MARGINAL
Other recent JEEP records in the index.
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042177HexarelinJEEP-2608-Y9547Janoshik2026-Q399.903.42Buyer-sourced0PASS
AX-2026-042162SemaglutideJEEP-2607-X9091Janoshik2026-Q398.983.46Laboratory-retained1MARGINAL
AX-2026-042127TB-500JEEP-2602-V8614Medutest2026-Q399.683.55Buyer-sourced1FAIL
AX-2026-042123TB-500JEEP-2602-V8614PeptideMeter2026-Q399.933.80Buyer-sourced0PASS
AX-2026-042124TB-500JEEP-2602-V8614PeptideMeter2026-Q399.913.37104.9Buyer-sourced0PASS
AX-2026-042178HexarelinJEEP-2608-Y9547VendorInvestigate2026-Q399.684.03Buyer-sourced0PASS
AX-2026-042163SemaglutideJEEP-2607-X9091Nordanalyt2026-Q399.464.52Buyer-sourced1MARGINAL
AX-2026-042122TB-500JEEP-2602-V8614PeptideMeter2026-Q399.603.5897.0Buyer-sourced0PASS